Shandong Weigao Group Medical Polymer Co. Ltd. | Mutual Funds
Mutual Funds that own Shandong Weigao Group Medical Polymer Co. Ltd.
Seafarer Overseas Growth & Income Fund
55,000,000
1.22%
-6,250,000
2.11%
06/30/2018
Templeton Foreign Fund
42,940,060
0.95%
42,940,060
0.6%
03/31/2018
Fidelity Funds SICAV - China Focus Fund
39,953,318
0.88%
40,950
0.88%
05/31/2018
Invesco Funds - Greater China Equity Fund
34,928,000
0.77%
10,192,000
2.81%
03/29/2018
Government Pension Fund - Global (The)
32,256,123
0.71%
-9,211,600
0%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
27,331,699
0.6%
-280,000
0.03%
07/31/2018
Vanguard Total International Stock Index Fund
25,049,672
0.55%
1,944,000
0.01%
07/31/2018
Schroder ISF - China Opportunities
22,780,000
0.5%
0
2.23%
05/31/2018
Wells Fargo Advantage Emerging Markets Equity Fund
18,024,000
0.4%
0
0.44%
07/31/2018
UBS (Lux) Equity Fund - China Opportunity
16,692,000
0.37%
0
0.42%
01/31/2018
About Shandong Weigao Group Medical Polymer Co.
View Profile
| Address |
18 Xingshan Road
Weihai Shandong 264210
China
|
|
Employees
|
- |
| Website |
http://www.weigaogroup.com |
| Updated |
07/08/2019 |
| Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical devices. It operates through the following segments: Single Use Medical Device Products, Orthopedic Products, and Others. The Single Use Medical Device Products segment involves in the production and sale of single use consumables such as infusion sets, syringes, blood transfusion sets, and blood bags. |
